Global Antibiotic R&D Partnership (GARDP)

📺 Missed our webinar? Watch our latest webinar to hear experts discuss the barriers to antibiotic access in high-burden settings and the approval of zoliflodacin in Thailand just six months after US FDA approval. 🎥 https://youtu.pulse.ly/vytadx0fcg

🎉 Big congratulations to DNDi on this important milestone! It’s great to see the Alliance grow, bringing together more institutions across dengue-endemic countries to move research forward and expand treatment options.

In a 🆕 #REVIVE Antimicrobial Viewpoint, Dr Teodora Elvira C. Wi examines the growing threat of drug-resistant gonorrhoea, from ceftriaxone resistance to the promise of new antibiotics, better diagnostics and vaccines. 🔗Read the full Viewpoint: revive.gardp.org/antimicrobia...

Too many antibiotics in development are variations of existing treatments. Tackling antimicrobial resistance demands genuine innovation. GARDP focuses antibiotic R&D on WHO priority pathogens, directing innovation towards the greatest unmet needs & public health impact. #AMR #AntibioticResistance

At a recent national consultation in Delhi, GARDP, IIPH-Delhi and PHFI brought stakeholders together to advance a Strategic Roadmap for India, co-convened with FICCI, with ICMR as technical and advisory partner. #ResponsibleAccess #AMR

REVIVE resources are now featured in PACE’s Therapeutics Resources Directory, a curated collection of webinars, guidance, databases and practical tools covering the journey from early discovery to regulatory approval. 🔗https://paceamr.org.uk/therapeutics-resources-directory/

💊As resistance grows, yesterday’s antibiotics may fall short. GARDP is working to expand options for gonorrhoea with zoliflodacin, a first-in-class, single-dose oral antibiotic, and working to expand global access to new treatments. AMR is BIG. Our response is BIGGER. 🔗 tinyurl.com/e3thex7y

🌍At #WHS2026 in Berlin, global leaders confronted urgent questions around financing, country leadership and health innovation's future. GARDP Board Chair Glenda Gray makes the case for keeping #AMR, and investment in new antibiotics, firmly on the global agenda. @worldhealthsummit.bsky.social

At #IUSTI2026 in Prague, GARDP and partners explored how evidence on antimicrobial resistance, disease burden, health economics and patient pathways can inform policy and clinical practice. #Gonorrhoea #AMR #Zoliflodacin

A new joint perspective paper from GARDP, @dndi.org, @mmv.org and MDGH sets out 7 recommendations to strengthen the WHO functions that support needs-driven R&D and access, particularly where commercial incentives are limited. 📄 gardp.org/strengthenin...

📅 Abstract deadline: 16 Nov 2026, 17:00 GMT Antimicrobial chemotherapy researchers are invited to submit abstracts to #ACC2027, a free, virtual conference on #AMR organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as the 2027 collab org. 👉 acc-conference.com#posters

ICMR and GARDP convened leading voices from India's health ecosystem to set priorities for tackling #AMR in India. The consultation will help shape GARDP’s 2027–2031 strategy for India, identifying opportunities to improve access to antibiotics and accelerate the development of new treatments.

At @worldhealthsummit.bsky.social in Berlin, @dndi.org, @gardp.bsky.social & MMV invited partners to explore how stronger collaboration can sustain health innovation, strengthen local capabilities and accelerate access to the treatments people need. Turning shared ambition into collective action.

📹Herman Goossens, Emeritus Professor at the University of Antwerp, explains why sustained investment in R&D, clinical trials, manufacturing and equitable access is essential to secure the future of antibiotics. #AMRIsBig #OurResponseIsBigger

A new #REVIVE antimicrobial viewpoint examines China’s experience translating AMR policy into practice, and what its progress, persistent gaps and approach to stewardship, One Health and antimicrobial innovation can teach us about implementation at scale. 🔗 revive.gardp.org/the-current-...

Lord Darzi hosted a working lunch at the House of Lords this week, convened with GARDP, in his new role as GARDP Advocate. Guests from Parliament, government, the NHS, research and industry discussed AMR resilience, financing and partnership. #AMR

📢 We’re hiring ! Join GARDP to lead strategy and delivery across R&D, access and partnerships, advancing new and existing antibiotics for serious bacterial infections. 🔗 apply.workable.com/gardp/j/A112... #Hiring #GARDP #AMR

At the 63rd PAHO Directing Council, Member States approved the Plan of Action on AMR 2027–2031. GARDP and PAHO’s work on surveillance, diagnostics, Reserve antibiotic access and R&D supports the Plan’s priorities. We look forward to contributing to its implementation. 🔗https://tinyurl.com/yvs8ryxd

New gonorrhoea treatments need a clear pathway from evidence to policy and practice. At #IUSTI2026, GARDP and partners will discuss the evidence needed to guide responsible introduction and maximise public health impact. 📍 South Hall 2A 📅 16 Oct, 13:00–14:25 #AMR

🤝In 2026, #REVIVE welcomes 19 new experts to its global community, bringing expertise across infectious diseases, microbiology, epidemiology, drug discovery, clinical research, regulatory affairs and #AMR. Different expertise. Diverse perspectives. One shared commitment: tackling AMR.

What if antibiotic access focused not on overuse vs underuse, but optimal use? 📅Join GARDP on 27 Oct, 12:00 PM CET to explore how effective treatments can reach high-burden populations and lessons from zoliflodacin’s Thailand approval. 🔗 Register: tinyurl.com/3xfm77hc @advance-id.bsky.social

🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.

🌎 For the first time, GARDP is participating in the PAHO Directing Council, joining health authorities from across the Americas to discuss shared public health priorities. 💊Our work with PAHO is strengthening AMR surveillance, research and antibiotic access. 🎥See the work taking shape in LatAm.

🚀 #GAMRIC2026 kicks off in Lisbon For the next three days, people working across #AMR are coming together to talk about what is changing in the science, where the gaps remain, and what it will take to develop better tools against AMR. Come meet the team!

#GAMRIC2026 starts tomorrow! We are excited to welcome you to Lisbon, Portugal and hope you enjoy the innovative programme and opportunities to connect. Follow along over the next days as we cover highlights from the conference. LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)

#ACC2027 registration & abstract submissions are open! Join the free, virtual conference on #AMR jointly organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as collaborating organization for 2027. 🔗Register: tinyurl.com/mr2bftrv 👉Submit an abstract: tinyurl.com/bddwc49x

In Brazil, GARDP & Fiocruz are working with hospitals & labs to understand resistance profiles for the responsible use of Reserve antibiotics, including susceptibility to cefiderocol. Microbiologists recently trained at Fiocruz’s LABSUR for training in antimicrobial susceptibility testing.

Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW

#FungalAwarenessWeek2026 | 2 days to go! Join #REVIVE on 17 Sept for our webinar exploring newer azoles, extended dosing, long half-life echinocandins and novel antifungals, with a live Q&A. attendee.gotowebinar.com/register/754...

In Germany, earlier diagnosis helps patients receive treatment for sepsis sooner, but AMR is making infections harder to treat. Peter Beyer writes in Tagesspiegel Background on why sepsis investment must include new antibiotics: tinyurl.com/3pt7tama #WorldSepsisDay #AMRIsBig #OurResponseIsBigger

Personalized phage therapy has strong biological promise. But making it part of routine #AMR care will depend on stronger infrastructure. A new #REVIVE viewpoint explores what it will take to scale. 🔗https://tinyurl.com/53y2pf54

💻 Register for #REVIVE’s 29 Sept webinar on clinical trial evidence shaping antibiotic use. ⏰29 Sept | 13:30 - 15:00 CEST attendee.gotowebinar.com/register/261... @jesusrbano.bsky.social I @clarityinitiative.bsky.social

STARTING 🔜 Join the #WorldSepsisDay webinar exploring how neonatal antimicrobial stewardship can improve antibiotic use today and help protect treatment options for tomorrow. GARDP’s Justin Green will be joining the expert discussion.

Journalist Md Zahid Hossain Khan investigates AMR in Bangladesh’s ICUs and NICUs in a new Daily Sun feature. The story is part of GARDP’s first-ever #WithoutBordersMediaFellowship, supporting in-depth AMR reporting across South Asia. 🔗Read the full article here: www.daily-sun.com/health/89640...

📅 Save the date: 9–11 Feb 2027 The #ACC2027 is a free, open-access virtual conference, jointly organised by @bsacandjac.bsky.social and GARDP within the framework of the @eupohamr.bsky.social. More info coming soon! 🌐Explore the website: acc-conference.com

Developing a new antibiotic is only half the race. 🌍 But it's equally important that treatments reach the countries and communities with the greatest need, without unnecessary delays. 💊At GARDP, we believe antibiotic innovation and access must go hand in hand in the fight against #AMR.

Learn how public-private partnerships help facilitate drug development, advance research, provide financing and share risks in this REVIVE Encyclopaedia video featuring Clara Maure from GARDP. 🎥 revive.gardp.org/resource/pub... #AMR #REVIVE

What would happen if antibiotics stopped working? In a recent interview with GARDP, Dr. Norio Ohmagari discusses the growing threat of AMR, the challenges facing antibiotic development and the importance of global collaboration. 🔗Read the full interview: gardp.org/healthcare-i...